Usefulness of c-arm angiographic computed tomography for detecting iodized oil retention during transcatheter arterial Chemoembolization of Hepatocellular carcinoma

Journal of International Medical Research

Volumn 38, Issue 4, 2010, Pages 1259-1265

  Sun, J H ^a   Wang, L G ^a   Bao, H W ^a   Lou, J L ^a   Cai, L X ^a   Wu, C ^a   Chen, L M ^a   Zheng, S S ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C arm angiographic CT; Chemoembolization; Digital subtraction angiography; Hepatocellular carcinoma; Liver neoplasms

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL; OXALIPLATIN;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RETENTION; DRUG TUMOR LEVEL; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; MALE;

EID: 77957726486     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800407     Document Type: Article

References (29)

1. He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-1134.
2. Jiang Y, Zhang SH, Han GQ, et al: Association of programmed cell death factor 4 (PDCD4) with hepatocellular carcinoma and smoking in a Chinese male population. J Int Med Res 2009; 37: 1179-1183.
3. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
4. Parkin DM, Bray F, Ferlay J, et al: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
5. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36(5 suppl 1): S74-S83.
6. Yu SC, Hui JW, Hui EP, et al: Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization. J Vasc Interv Radiol 2009; 20: 352-359.
7. Ulmer SC: Hepatocellular carcinoma: a concise guide to its status and management. Postgrad Med 2000; 107: 117-124.
8. Vogl TJ, Trapp M, Schroeder H, et al: Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000; 214: 349-357.
9. Alsowmely AM, Hodgson HJ: Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002; 16: 1-15.
10. Colagrande S, Fargnoli R, Dal Pozzo F, et al: Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma. J Comput Assist Tomogr 2000; 24: 878-883.
11. Higashi S, Tabata N, Kondo KH, et al: Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther 1999; 289: 816-819.
12. Nakayama A, Imamura H, Matsuyama Y, et al: Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg 2001; 234: 56-62.
13. Chen MS, Li JQ, Zhang YQ, et al: High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 2002; 8: 74-78.
14. Oi H, Kim T, Kishimoto H, et al: Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33(suppl): S69-S73.
15. Oi H, Kishimoto H, Matsushita M, et al: Antitumor effect of transcatheter oily chemoembolization for hepatocellular carcinoma assessed by computed tomography: role of iodized oil. Semin Oncol 1997; 24(2 suppl 6): S6-56-S6-60.
16. Nakayama A, Imamura H, Matsuyama Y, et al: Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg 2001; 234: 56-62.
17. Kakeda S, Korogi Y, Ohnari N, et al: Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol 2007; 18: 1508-1516.
18. Virmani S, Ryu RK, Sato KT, et al: Effect of Carm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 2007; 18: 1305-1309.
19. Matsuo N, Uchida H, Sakaguchi H, et al: Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 1997; 24(2 suppl 6): S6-61-S6-70.
20. Befeler AS, Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619.
21. Llado L, Virgili J, Figueras J, et al: A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000; 88: 50-57.
22. Amesur NB, Zajko AB, Carr BI: Chemoembolization for unresectable hepatocellular carcinoma with different sizes of embolization particles. Dig Dis Sci 2008; 53: 1400-1404.
23. Pelletier G, Ducreux M, Gay F, et al: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998; 29: 129-134.
24. Savastano S, Miotto D, Casarrubea G, et al: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 1999; 28: 334-340.
25. Takayasu K, Arii S, Matsuo N, et al: Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 2000; 175: 699-704.
26. Bizollon T, Rode A, Bancel B, et al: Diagnostic value and tolerance of lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers. J Hepatol 1998; 28: 491-496.
27. Caturelli E, Siena DA, Fusilli S, et al: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 2000; 215: 123-128.
28. Acunas B, Rozanes I: Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization. Eur J Radiol 1999; 32: 86-89.
29. Heran NS, Song JK, Namba K, et al: The utility of DynaCT in neuroendovascular procedures. AJNR Am J Neuroradiol 2006; 27: 330-332.